AQR Arbitrage LLC - LIGAND PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
AQR Arbitrage LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$10,834,000
+6.6%
11,422,000
+2.2%
0.38%
+3.0%
Q3 2020$10,165,000
+10.0%
11,178,000
+6.4%
0.37%
-10.2%
Q2 2020$9,240,000
-16.9%
10,506,000
-21.8%
0.41%
+10.5%
Q1 2020$11,123,000
-44.9%
13,431,000
-42.4%
0.37%
+9.1%
Q4 2019$20,189,000
+3.5%
23,325,0000.0%0.34%
+19.6%
Q3 2019$19,499,000
+17.0%
23,325,000
+21.2%
0.28%
+50.0%
Q2 2019$16,668,00019,250,0000.19%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CANYON CAPITAL ADVISORS LLC 40,000,000$38,988,0001.44%
Penn Mutual Asset Management, LLC 1,204,000$1,174,0001.36%
TFG Asset Management GP Ltd 21,600,000$21,148,0000.96%
PALISADE CAPITAL MANAGEMENT, LP 10,006,000$9,832,0000.23%
TENOR CAPITAL MANAGEMENT Co., L.P. 11,645,000$11,431,0000.22%
OAKTREE CAPITAL MANAGEMENT LP 20,353,000$19,882,0000.21%
Wellesley Asset Management 2,304$2,245,0000.15%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 10,000,000$9,719,0000.12%
SSI INVESTMENT MANAGEMENT LLC 2,000,000$1,942,0000.11%
Cutler Capital Management, LLC 300,000$291,0000.10%
View complete list of LIGAND PHARMACEUTICALS INC shareholders